Mirae Asset Global ETFs Holdings’s ResMed RMD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.18M	Buy	26,592 +1,146	+5%	+$238K	0.01%	846
2026 Q1	$5.71M	Sell	25,446 -1,566	-6%	-$390K	0.01%	792
2025 Q4	$6.51M	Sell	27,012 -25,193	-48%	-$6.44M	0.01%	733
2025 Q3	$14.3M	Buy	+52,205	New	+$14.3M	0.02%	535
2025 Q2	–	Sell	-40,320	Closed	-$9.03M	–	3200
2025 Q1	$9.03M	Sell	40,320 -241	-0.6%	-$56.3K	0.02%	611
2024 Q4	$9.28M	Sell	40,561 -3,082	-7%	-$742K	0.02%	585
2024 Q3	$10.7M	Sell	43,643 -3,341	-7%	-$747K	0.02%	534
2024 Q2	$8.99M	Buy	+46,984	New	+$9.53M	0.02%	575

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RMD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its ResMed (RMD) stake by 4.5% in Q2 2026, buying an estimated $238K and bringing the position to 26,592 shares worth $5.18M. The position accounts for 0.01% of the portfolio, ranked #846.

Mirae Asset Global ETFs Holdings first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $14.3M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Mirae Asset Global ETFs Holdings held 26,592 shares of ResMed worth $5.18M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,146 ResMed shares in Q2 2026, an estimated $238K.
ResMed made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #846 holding.
Mirae Asset Global ETFs Holdings first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's ResMed position peaked at $14.3M in Q3 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.